Skip to main content
Top
Gepubliceerd in: Journal of Autism and Developmental Disorders 6/2022

20-07-2021 | Letter to the Editor

Case Reports: Clozapine for the Treatment of Catatonia in Autism Spectrum Disorder

Auteurs: Robyn P. Thom, Christopher J. McDougle

Gepubliceerd in: Journal of Autism and Developmental Disorders | Uitgave 6/2022

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Catatonia is a severe clinical syndrome which has been increasingly reported in autism spectrum disorder (ASD). The prevalence of catatonia in ASD is unknown. Diagnosing catatonia in ASD is complicated by overlapping clinical features such as mutism, stereotypies, and echophenomena. Here, we present the clinical histories of two individuals with ASD and catatonia who were successfully treated with clozapine. We have reported on a novel potential treatment option for catatonia in ASD. Additional studies are needed to evaluate the safety, efficacy, and tolerability of clozapine for the treatment of catatonia in ASD.
Literatuur
go back to reference Billstedt, E., Gillberg, C., & Gillberg, C. (2005). Autism after adolescence: Population-based 13- to 22-year follow-up study of 120 individuals with autism diagnosed in childhood. Journal of Autism and Developmental Disorders, 35(3), 351–360.CrossRef Billstedt, E., Gillberg, C., & Gillberg, C. (2005). Autism after adolescence: Population-based 13- to 22-year follow-up study of 120 individuals with autism diagnosed in childhood. Journal of Autism and Developmental Disorders, 35(3), 351–360.CrossRef
go back to reference Chattopadhyay, S., Saha, I., Dan, A., & Bhattacharyya, K. (2012). Clozapine responsive catatonia: A series of five cases. Industrial Psychiatry Journal, 21(1), 66.CrossRef Chattopadhyay, S., Saha, I., Dan, A., & Bhattacharyya, K. (2012). Clozapine responsive catatonia: A series of five cases. Industrial Psychiatry Journal, 21(1), 66.CrossRef
go back to reference Collins, J., Halder, N., & Chaudhry, N. (2012). Use of ECT in patients with an intellectual disability: Review. The Psychiatrist, 36(2), 55–60.CrossRef Collins, J., Halder, N., & Chaudhry, N. (2012). Use of ECT in patients with an intellectual disability: Review. The Psychiatrist, 36(2), 55–60.CrossRef
go back to reference DeJong, H., Bunton, P., & Hare, D. J. (2014). A systematic review of interventions used to treat catatonic symptoms in people with autistic spectrum disorders. Journal of Autism and Developmental Disorders, 44(9), 2127–2136.CrossRef DeJong, H., Bunton, P., & Hare, D. J. (2014). A systematic review of interventions used to treat catatonic symptoms in people with autistic spectrum disorders. Journal of Autism and Developmental Disorders, 44(9), 2127–2136.CrossRef
go back to reference Dhossche, D. M., Shah, A., & Wing, L. (2006). Blueprints for the assessment, treatment, and future study of catatonia in autism spectrum disorders. International Review of Neurobiology, 72, 267–284.CrossRef Dhossche, D. M., Shah, A., & Wing, L. (2006). Blueprints for the assessment, treatment, and future study of catatonia in autism spectrum disorders. International Review of Neurobiology, 72, 267–284.CrossRef
go back to reference Dhossche, D. M., & Stanfill, S. (2004). Could ECT be effective in autism? Med Hypotheses [internet], 63(3), 371–376.CrossRef Dhossche, D. M., & Stanfill, S. (2004). Could ECT be effective in autism? Med Hypotheses [internet], 63(3), 371–376.CrossRef
go back to reference Ellul, P., Rotgé, J. Y., & Choucha, W. (2015). Resistant catatonia in a high-functioning autism spectrum disorder patient successfully treated with amantadine [Internet]. Journal of Child and Adolescent Psychopharmacology, 25(9), 726.CrossRef Ellul, P., Rotgé, J. Y., & Choucha, W. (2015). Resistant catatonia in a high-functioning autism spectrum disorder patient successfully treated with amantadine [Internet]. Journal of Child and Adolescent Psychopharmacology, 25(9), 726.CrossRef
go back to reference England, M. L., Öngür, D., Konopaske, G. T., & Karmacharya, R. (2011). Catatonia in psychotic patients: Clinical features and treatment response. Journal of Neuropsychiatry and Clinical Neurosciences, 23(2), 223–226.CrossRef England, M. L., Öngür, D., Konopaske, G. T., & Karmacharya, R. (2011). Catatonia in psychotic patients: Clinical features and treatment response. Journal of Neuropsychiatry and Clinical Neurosciences, 23(2), 223–226.CrossRef
go back to reference Fink, M., Taylor, M. A., & Ghaziuddin, N. (2006). Catatonia in autistic spectrum disorders: A medical treatment algorithm. International Review of Neurobiology, 72, 233–244.CrossRef Fink, M., Taylor, M. A., & Ghaziuddin, N. (2006). Catatonia in autistic spectrum disorders: A medical treatment algorithm. International Review of Neurobiology, 72, 233–244.CrossRef
go back to reference Ghaziuddin, N., Dhossche, D., & Marcotte, K. (2012). Retrospective chart review of catatonia in child and adolescent psychiatric patients. Acta Psychiatrica Scand., 125(1), 33–38.CrossRef Ghaziuddin, N., Dhossche, D., & Marcotte, K. (2012). Retrospective chart review of catatonia in child and adolescent psychiatric patients. Acta Psychiatrica Scand., 125(1), 33–38.CrossRef
go back to reference Honigfeld, G., Arellano, F., Sethi, J., Bianchini, A., & Schein, J. (1998). Reducing clozapine-related morbidity and mortality: 5 years of experience with the Clozaril National Registry. Journal of Clinical Psychiatry, 59(SUPPL. 3), 3–7.PubMed Honigfeld, G., Arellano, F., Sethi, J., Bianchini, A., & Schein, J. (1998). Reducing clozapine-related morbidity and mortality: 5 years of experience with the Clozaril National Registry. Journal of Clinical Psychiatry, 59(SUPPL. 3), 3–7.PubMed
go back to reference Horder, J., Petrinovic, M. M., Mendez, M. A., et al. (2018). Glutamate and GABA in autism spectrum disorder-a translational magnetic resonance spectroscopy study in man and rodent models. Translational Psychiatry, 8(1), 106.CrossRef Horder, J., Petrinovic, M. M., Mendez, M. A., et al. (2018). Glutamate and GABA in autism spectrum disorder-a translational magnetic resonance spectroscopy study in man and rodent models. Translational Psychiatry, 8(1), 106.CrossRef
go back to reference Jann, M. W. (1991). Clozapine. Pharmacother J Hum Pharmacol Drug Ther, 11(3), 179–195. Jann, M. W. (1991). Clozapine. Pharmacother J Hum Pharmacol Drug Ther, 11(3), 179–195.
go back to reference Lamberti, J. (2006). Prevalence of the metabolic syndrome among patients receiving clozapine. American Journal of Psychiatry, 163(7), 1273.CrossRef Lamberti, J. (2006). Prevalence of the metabolic syndrome among patients receiving clozapine. American Journal of Psychiatry, 163(7), 1273.CrossRef
go back to reference Marrosu, F., Marrosu, G., Rachel, M. G., & Biggio, G. (1987). Paradoxical reactions elicited by diazepam in children with classic autism. Functional Neurology, 2(3), 355–361.PubMed Marrosu, F., Marrosu, G., Rachel, M. G., & Biggio, G. (1987). Paradoxical reactions elicited by diazepam in children with classic autism. Functional Neurology, 2(3), 355–361.PubMed
go back to reference Meltzer, H. Y. (2012). Clozapine: Balancing safety with superior antipsychotic efficacy. Clinical Schizophrenia & Related Psychoses, 6(3), 134–144.CrossRef Meltzer, H. Y. (2012). Clozapine: Balancing safety with superior antipsychotic efficacy. Clinical Schizophrenia & Related Psychoses, 6(3), 134–144.CrossRef
go back to reference Pelzer, A. C. M., van der Heijden, F. M. M. A., & den Boer, E. (2018). Systematic review of catatonia treatment. Neuropsychiatric Disease and Treatment, 14, 317–326.CrossRef Pelzer, A. C. M., van der Heijden, F. M. M. A., & den Boer, E. (2018). Systematic review of catatonia treatment. Neuropsychiatric Disease and Treatment, 14, 317–326.CrossRef
go back to reference Rosebush, P. I., & Mazurek, M. F. (2010). Catatonia and its treatment. Schizophrenia Bulletin, 36(2), 239–242.CrossRef Rosebush, P. I., & Mazurek, M. F. (2010). Catatonia and its treatment. Schizophrenia Bulletin, 36(2), 239–242.CrossRef
go back to reference Siskind, D., McCartney, L., Goldschlager, R., & Kisely, S. (2016). Clozapine v first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis. British Journal of Psychiatry, 209(5), 385–392.CrossRef Siskind, D., McCartney, L., Goldschlager, R., & Kisely, S. (2016). Clozapine v first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis. British Journal of Psychiatry, 209(5), 385–392.CrossRef
go back to reference Wing, L., & Shah, A. (2000). Catatonia in autistic spectrum disorders. British Journal of Psychiatry, 176, 357–362.CrossRef Wing, L., & Shah, A. (2000). Catatonia in autistic spectrum disorders. British Journal of Psychiatry, 176, 357–362.CrossRef
go back to reference Wu, Y., Blichowski, M., Daskalakis, Z. J., et al. (2011). Evidence that clozapine directly interacts on the GABAB receptor. NeuroReport, 22(13), 637–641.CrossRef Wu, Y., Blichowski, M., Daskalakis, Z. J., et al. (2011). Evidence that clozapine directly interacts on the GABAB receptor. NeuroReport, 22(13), 637–641.CrossRef
Metagegevens
Titel
Case Reports: Clozapine for the Treatment of Catatonia in Autism Spectrum Disorder
Auteurs
Robyn P. Thom
Christopher J. McDougle
Publicatiedatum
20-07-2021
Uitgeverij
Springer US
Gepubliceerd in
Journal of Autism and Developmental Disorders / Uitgave 6/2022
Print ISSN: 0162-3257
Elektronisch ISSN: 1573-3432
DOI
https://doi.org/10.1007/s10803-021-05149-8

Andere artikelen Uitgave 6/2022

Journal of Autism and Developmental Disorders 6/2022 Naar de uitgave